BROOKE CEMPER: Open Payments
NPI 1174983100 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 65 payments from 14 companies in 2025. Trend: 2023 $943 · 2024 $1,278 · 2025 $1,324
Food & beverage: $1,273Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $409 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $246 |
| Janssen Biotech, Inc. | 7 | $165 |
| Ipsen Biopharmaceuticals, Inc | 5 | $120 |
| Madrigal Pharmaceuticals | 3 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 5 | $46 |
| STERIS CORPORATION | 1 | $43 |
| Lilly USA, LLC | 2 | $35 |
Products named: ENTYVIO, RINVOQ, TREMFYA, IQIRVO, SKYRIZI, LINZESS, REZDIFFRA, ZENPEP.
Industry payments across NE — which companies pay providers there.
